Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model |
|
The immunopathogenicity of cytokines in viral infections |
|
Miscarriage Associated with Zika Virus Infection |
|
Modeling host genetic regulation of influenza pathogenesis in the collaborative cross |
|
[Modern methods for the development of antiviral vaccines] |
|
Moderne technieken voor de ontwikkeling van antivirale vaccins |
|
Molecular epidemiology of gibbon hepatitis B virus transmission. |
|
Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins |
|
Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha. |
|
Naturally occurring recombination in ferret coronaviruses revealed by complete genome characterization |
|
Neutrophil extracellular traps persist at high levels in the lower respiratory tract of critically ill COVID-19 patients |
|
Neutrophil induced T-cell apoptosis during a viral infection |
|
New viruses in idiopathic human diarrhea cases, the Netherlands |
|
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations? |
|
Novel cyclovirus in human cerebrospinal fluid, Malawi, 2010-2011. |
|
Novel divergent nidovirus in a python with pneumonia |
|
Novel hepatitis E virus in ferrets, the Netherlands |
|
Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014. |
|
An Organoid-derived Bronchioalveolar Model for SARS-CoV-2 Infection of Human Alveolar-type II-like Cells |
|
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels |
|
Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV |
|
The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. |
|
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response |
|
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. |
|
Persistence and evolution of feline coronavirus in a closed cat-breeding colony |
|
Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome |
|
Phenotypic Differences between Asian and African Lineage Zika Viruses in Human Neural Progenitor Cells |
|
Picobirnaviruses in the human respiratory tract |
|
Pneumococcal conjugate vaccines |
|
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability |
|
Presence of anti-interferon antibodies is not associated with non-response to pegylated interferon treatment in chronic hepatitis B. |
|
Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection |
|
Prostate cancer gene therapy: Preliminary clinical and pre-clinical results |
|
Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant |
|
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection |
|
Rat testicular germ cells and Sertoli cells release different types of bioactive transforming growth factor beta in vitro |
|
The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies |
|
Reliable typing of MERS-CoV variants with a small genome fragment |
|
A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. |
|
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms |
|
Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Infection in Camel Workers in Qatar During 2013-2014: A Case-Control Study |
|
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial |
|
The sample of choice for detecting Middle East respiratory syndrome coronavirus in asymptomatic dromedary camels using real-time reversetranscription polymerase chain reaction |
|
SARS |
|
SARS-CoV-2 is transmitted via contact and via the air between ferrets |
|
The SARS-CoV-2 multibasic cleavage site facilitates early serine protease-mediated entry into organoid-derived human airway cells |
|
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model |
|
SARS-CoV-2 Productively Infects Human Gut Enterocytes |
|
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans |
|
Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia |
|
Severe COVID-19 patients display a back boost of seasonal coronavirus-specific antibodies |
|
Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants |
|
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 |
|
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 |
|
Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. |
|
Susceptibility of rabbits to SARS-CoV-2 |
|
T-Cell tropism of simian varicella virus during primary infection |
|
Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens |
|
Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics |
|
Tissue Distribution of the MERS-Coronavirus Receptor in Bats |
|
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein |
|
Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment. |
|
Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection |
|
Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. |
|
Tumour necrosis factor- , interferon- and interferon-beta exert antiviral activity in nervous tissue cells |
|
Tumour necrosis factor- production during cytomegalovirus infection in immunosuppressed rats |
|
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy |
|
Unraveling the complexities of the interferon response during SARS-CoV infection |
|
Updated phylogenetic analysis of arenaviruses detected in boid snakes |
|
Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D. |
|
Virogenomics: the virus-host interaction revisited |
|
Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen |
|
Virology: SARS virus infection of cats and ferrets |
|
Virus genomes reveal the factors that spread and sustained the West African Ebola epidemic |
|
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. |
|